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To explore possible working mechanisms of anxiety reduction in women with anxiety disor-
ders, treated with art therapy (AT).
Methods
A RCT comparing AT versus waiting list (WL) condition on aspects of self-regulation. Stress
regulation (heart rate and heart rate variability) and executive functioning (daily behavioural
and cognitive performance aspects of executive functioning (EF)) were evaluated in a pre-
post design. Participants were women, aged 18–65 years with moderate to severe anxiety
symptoms.
Results
Effectiveness of AT compared to WL was demonstrated in a higher resting HRV post treat-
ment, improvements in aspects of self-reported daily EF (emotion control, working memory,
plan/organize and task monitor), but not in cognitive performance of EF, stress responsive-
ness and down regulation of stress. The decrease in anxiety level was associated with
improvements in self-reported daily EF.
Conclusions
AT improves resting HRV and aspects of EF, the latter was associated with art therapy-
related anxiety reduction.
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Introduction
Every person experiences fear and anxiety in life to some degree, but for people with an anxiety
disorder, the anxiety increases over time, is disproportionate to the actual danger or threat and
becomes permanent [1].
The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) [1] distinguishes
between different types of anxiety disorders. The most common anxiety disorders are phobias,
followed by social anxiety disorder (SAD), generalized anxiety disorder (GAD) and panic dis-
order (PD) [2]. Although the anxiety disorders may have different triggers, they share underly-
ing features [3, 4]. An important feature that applies to all anxiety disorders is the exaggerated
cognitive appraisal that is associated with the threatening situation: hyper-alert cognitive
schemes lead to pathological anxiety [5].
Anxiety consists of physiological, emotional and cognitive aspects, and arises from specific
personal characteristics combined with genetic, neurobiological and social factors [6], includ-
ing hypersensitivity to stress and the tendency to experience strong negative emotions
(nervousness, sadness, anger). According to Clark and Watson [7], anxiety is characterized by
negative affect and high physiological hyperarousal. Anxiety disorders are associated with dys-
functions in self-regulation [8, 9], such as problems concerning emotion regulation, stress reg-
ulation (hyperarousal) and difficulties with cognitive regulation.
Treatment of anxiety is often aiming at changing maladaptive beliefs through cognitive
behavioural therapy [10,11] and/or reducing anxiety symptoms through medication. Art ther-
apy (AT) is also often provided in anxiety disorders, although little is known about its effective-
ness. AT is a non-verbal, so-called ‘experience-oriented’ intervention that uses the visual arts
(e.g. painting, drawing, sculpting, clay modelling) and is provided as standalone therapy or in
multidisciplinary treatment programs for anxiety disorders. Outcomes of a RCT comparing
three months AT with three months waiting list condition in women with anxiety disorders
showed that anxiety symptoms can be reduced by AT and that there are indications that
improved perceived emotion regulation plays a role in this reduction [12]. However, other
aspects of self-regulation may also play a role in the reduction of anxiety symptom severity. As
discussed above, individuals suffering from anxiety have also problems concerning stress regu-
lation and difficulties with cognitive regulation, expressed as executive functioning.
Anxiety disorders and stress regulation
Stress regulation concerns dealing with stressors. People with anxiety problems usually have
stress responses that are typically accompanied by sweating, shaking, dizziness and increased
heart rate [13]. These physical reactions are driven by the autonomic nervous system in the
presence of a stressor. An indicator for the functioning of the autonomic nervous system is
heart rate variability (HRV), which refers to the fluctuations in heart rate, also known as the
variation in time between heartbeats (InterBeat Interval) [14, 15]. Parasympathetic influences
from the brainstem alter the heart rate, and HRV is thus an index of cardiac flexibility [16].
HRV decreases with age and cardiac comorbidities and increases with physical activity [17].
During stress, HR increases and HRV decreases due to more sympathetic and less parasympa-
thetic activation.
High HRV, expressing more variation in time between heart beats, is seen as an indicator
for a well-functioning autonomic nervous system, which can respond to varying demands in
different situations [15, 18]. HRV at rest (resting HRV) reflects self-regulation ability [19].
A review of 36 studies into the relationship between the presence of anxiety symptoms and
HRV, in people with anxiety disorders compared to control groups without anxiety symptoms
[20], reported that the presence of an anxiety disorder is significantly associated with lower
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HRV. This was the case for people with generalized anxiety disorder (GAD), social anxiety dis-
order (SAD) and panic disorder (PD): lower resting HRV is associated with PD, SAD [21] and
GAD [9, 21]. Lower HRV indicates autonomic inflexibility and deficits in anxiety related
inhibitory processes [21]. Resting HRV is lower in individuals that worry more [22] and have
high (trait) anxiety [23]. Decrease of HRV is shown in conditions of stress (e.g. time pressure),
emotional strain and increased anxiety [24]. Based on these findings, heart rate and heart rate
variability are considered physiological indicators of stress and anxiety [25]. An increase in
heart rate may be an indication of an increased emotional state [26].
Anxiety disorders and executive functioning
A risk factor in the development and persistence of anxiety disorders is a limitation in execu-
tive skills [27]. Executive functions (EFs) are cognitive processes that are necessary for efficient
and goal-oriented behaviour. Important EF components are inhibition (the ability to stop and
/ or slow down behaviour (actions and thoughts)), working memory (the collection of cogni-
tive processes that keep information temporarily accessible in order to perform mental tasks),
cognitive flexibility (changing and adjusting behaviour) and planning (being able to think
ahead and subdivide the process into intermediate steps towards a goal) [28, 29, 30].
Although the body of knowledge on the relationship between anxiety and EF is small, it is
assumed that anxiety disorders may be the result of suboptimal cognitive regulation processes
involving executive functioning. Difficulties with inhibition are found to be associated with
higher levels of anxiety symptoms. Problems with EF are a risk factor for developing social
anxiety [31] and adults with a generalized anxiety disorder are found to have more difficulties
with inhibition than healthy controls [32].
Present study
There is already some evidence for anxiety symptom reduction through AT and there are indi-
cations that improved perceived emotion regulation plays a role in this reduction [12]. To gain
further understanding of other regulating processes that might play a role in the reduction of
anxiety symptoms through AT, the question is addressed whether stress regulation and execu-
tive functioning improve as a result of AT and whether these mechanisms are related to the
reduction of anxiety symptoms and may provide (further) mechanistic evidence and explana-
tions of the AT treatment effect.
Some studies suggest a possible stress regulating effect of AT, since AT is thought to pro-
mote relaxation [33, 34]. AT is also believed to improve several aspects of executive function-
ing, like inhibition, because it is supposed to contribute to decrease of (a.o.) impulsivity [35,
36]. Based on these studies and expert opinions we hypothesized that AT treatment contrib-
utes to better stress regulation, because AT is thought to induce relaxation, presumably compa-
rable to mindfulness [37, 38] and may thus have a dampening effect on the arousal. This could
become visible in a lower stress response, improved down regulation after facing a stressor and
as a generally lower stress level which is reflected in a higher HRV at rest.
AT may also improve cognitive regulation, which can be reflected in improvement of sev-
eral aspects of executive functioning, like inhibition, sustained attention, flexibility, working
memory and task monitor, because these competences are needed to perform artistic exercises
and are thought to be practiced and trained during the therapy process.
Materials and methods
In a RCT design, comparing three months AT with three months waiting list condition in
women with anxiety disorders, psychophysiological outcomes (stress responsivity) as well as
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daily behavioural and cognitive performance aspects of executive functioning were measured.
Data were collected as part of a single-blind RCT on the effectiveness of art therapy in women
with anxiety disorders. Detailed information about the study is reported elsewhere [12]. The
study was approved by the Medical Ethics Committee of the Leiden University Medical Cen-
tre, the Netherlands (NL36861.018.11) and the trial was registered in the Dutch Trial Registra-
tion (https://www.trialregister.nl/trial/6661).
Sample randomisation and intervention
Included were adult women, aged 18–65, with a primary diagnosis of generalized anxiety dis-
order, social phobia and/ or panic disorder (with or without agoraphobia) and with moderate
to severe anxiety symptoms (scoring >7 for anxiety and/or >10 for distress on the Four
Dimension Symptoms Questionnaire (4SDQ) [39]. Patients were excluded if they were aged
less than 18 years or older than 65 years, had psychosis or hallucinations, alcohol or drug
addiction, suicidal risk, brain pathology. All participants were recruited through posters/flyers
in the practices of family doctors and by social media.
Sample size
Based on a pre-post measurement difference in the primary outcome of 15% (considered to be
a clinically relevant LWASQ total score reduction), an alpha of 0.05, a power of 0.80 and a
dropout rate of 15%, the sample size was calculated: 60 participants in total (30 participants
per group) (http://clincalc.com/stats/samplesize.aspx).
Randomisation method and allocation concealment
A pre-stratification procedure was executed with four strata: use of psychotropic drugs (yes/
no), moderate or severe depression symptoms (4SDQ: depression >6) (yes/ no). After pre-
stratification, through block randomization (blocks of 2), participants were at random
assigned to either the treatment group (AT) or the control group (WL), according to a com-
puter-generated list (www.randomization.com). Blinding of art therapists and participants was
not possible.
The study took place at 25 private art therapy practices spread throughout the Netherlands,
in the period between January 2017 and March 2018.
A total of 59 women was included between January and July 2017. After pre-stratification
on comorbid depression symptom level and psychopharmaceutical use, randomization
resulted in an experimental group of 30 participants and a control group of 29 participants.
Intervention
The experimental group (AT group) received 10–12 sessions AT of one hour each, during a
period of three months. The specific intervention type was anthroposophic art therapy. The
control group (WL) was wait listed for three months. In order to assure that the intervention
tested in the study was representative for the general approach of this type of AT, only qualified
and registered Dutch anthroposophic art therapists, with more than five years’ experience in
working with adults with anxiety, treated the participants.
Study population
During the study, 12 patients (20%) dropped out and 47 patients (80%) completed the trial.
Dropouts concerned six from AT group and six from WL group, due to lack of time (n = 3),
not willing to wait for the intervention (n = 3), hospitalization or physical illness (n = 3), non-
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response (n = 2) and migration (n = 1). There were no significant differences between drop-
outs and completers on baseline parameters (T0), so per-protocol analysis was justified.
The participants in the two groups did not differ on key variables, including age, diagnosis,
use of medication, occupation, education and familiarity with anthroposophic healthcare and
outcome variables at baseline. The analysed sample of 47 patients had a mean age of 44.4 years
(SD = 14,0), moderate to severe anxiety symptoms: 11.2 (SD = 4.6) and a mean duration of
anxiety symptoms of 17.6 years (SD = 18.9) (range: three months—64 years (lifetime)). Medi-
cation for anxiety was used by 15 participants. Multiple diagnoses applied to all participants:
25 participants met the criteria for the diagnosis GAD, 21 for social phobia and 28 for panic
disorder. Ten participants suffered from (comorbid) PTSD, five participants had current
comorbid depression and 16 patients experienced one or more depressive episodes prior to
this study.
Procedure
The study contained two measurement waves: pre- and post-treatment, three months apart,
which consisted of online questionnaires and home-visits with physiological and neuropsy-
chological measurements. The online questionnaires were completed prior to the home-visit.
The protocol during the two home-visits at T0 and T1 included the measurement of stress reg-
ulation and of performance-based executive functioning. The measures at the home-visits
were taken by trained research assistants who were unaware of allocation. Outcome assessors
who judged and analysed the results were blinded as well.
Measures and instruments
Measures of stress regulation
Stress regulation was measured as stress responsiveness (response and recovery), with physio-
logical responses using a Biopac MP150 Acquisition System (Biopac Systems Inc., Santa Bar-
bara, CA) during a stress-evoking task (Fig 1), based on the Trier Social Stress Test (TSST)
[40]. The TSST is developed to measure regulation of the autonomic nervous system (ANS)
during stress.
Heart rate (HR), and heart rate variability (HRV) were recorded responses. Three ECG
electrodes were attached to the chest, one located near left mid-clavicular line directly below
the clavicle, one near the right mid-clavicular line and one between 6th and 7th intercostal
space on left mid-clavicular line. To stabilize the ECQ signal, a 2 Hz high pass filter and a 50
Hz notch filter were applied in AcqKnowledge software (version 0.3.0, Biopac System Inc). R-
peaks and IBIs were visually inspected and manually corrected by two researchers (AA and
DB). The corrected recordings were analysed using the PhysioData Toolbox, a MATLAB-
based application [41]. For each phase (resting, stress and cool down) we calculated mean HR:
mean of the continuous HR, as interpolated for the accepted Inter-Beat-Interval (IBI) data
point, and HRVRMSSD: the square root of the mean squared differences between successive
IBIs (nonadjacent IBIs disregarded). HRV is the variability in the distance between R peaks,
RR-interval or Inter-Beat-Interval (IBI) and refers to beat-to-beat alterations in heart rate
(HR). It is a measure of both sympathetic and parasympathetic influences on the heart (Levine
et al., 2016) and is related to emotional arousal [24].
The Root Mean Squared Successive Differences (RMSSD) of the HRV was used as this is
the recommended measure for calculating high frequency HRV from recordings of several
minutes since this measure is indicative for parasympathetic nervous system and is most com-
monly used and preferred to pNN50, as it has better statistical properties [42]. Normal
RMSSD mean value in a healthy population is 42ms (range 19–74) [17].
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Because of the vulnerability of the study population, it was decided that the experiment
would be stopped immediately if the subject indicated that she wanted to stop. Also, when
research assistants observed or suspected a too anxious, confused or emotional state, the sub-
ject was asked if she wanted to stop the experiment, and if so, it was stopped.
Measures of executive functioning
We used two measures of executive functioning: behavioural EF and cognitive EF. The daily
behavioural EF was measured with a self-report questionnaire (BRIEF-A) and cognitive
aspects of EF were measured with performance-based measures (subtests of the Amsterdam
Neuropsychological Tasks (ANT)).
The Dutch version of the Behaviour Rating Inventory of Executive Function for Adults
(BRIEF-A) was used to measure various aspects of daily executive functioning [43]. The
BRIEF-A is a questionnaire developed for adults, and it consists of 75 items with nine clinical
scales that measure various aspects of EF: four behavioural regulation scales and five metacog-
nition scales. The behaviour regulation scales are: inhibit: ability to control impulses (inhibi-
tory control) and to stop engaging in a behaviour; shift: cognitive flexibility, ability to move
freely from one activity or situation to another; to tolerate change; to switch or alternate atten-
tion; emotional control: ability to regulate emotional responses appropriately; and self-monitor:
ability to keep track of the effect of one’s own behaviour on other people. The metacognition
scales are: initiate: ability to begin an activity and to independently generate ideas or problem-
solving strategies; working memory: ability to hold information when completing a task, when
Fig 1. Content of the stress-evoking task.
https://doi.org/10.1371/journal.pone.0225200.g001
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encoding information, or when generating goals/plans in a sequential manner; plan/organize:
ability to anticipate future events; to set goals; to develop steps; to grasp main ideas; to organize
and understand the main points in written or verbal presentations; organization of materials:
ability to put order in work, play and storage spaces (e.g. desks, lockers, backpacks, and bed-
rooms); and task monitor: ability to check work and to assess one’s own performance. T-scores
were calculated from the raw scores. The ranges for the clinical scales are:<60 normal; 60–65
subclinical; >65 clinical [43].
For measuring cognitive performance-based aspects of executive functioning, the Amster-
dam Neuropsychological Tasks (ANT) a computer-aided assessment, was used. The ANT
allows for the systematic evaluation of neuropsychological performance [44]. It has been
proven to be a sensitive and valid tool in research on executive functions. Test–retest reliability
and validity of the ANT-tasks are satisfactory and have been extensively described elsewhere
(e.g. [45,46]).
A test battery of three tasks was chosen for this study: Baseline Speed (BS), Shifting Atten-
tion Set Visual (SSV) and Sustained Attention Dots Patterns (SAD). These tasks cover the fol-
lowing neuropsychological domains: alertness (intensity of attention) (BS), inhibition / mental
flexibility (SSV) and sustained attention (continuous performance) (SAD). These tasks are
shortly described, for detailed information including illustrations, see [47].
The BS task is a simple reaction time task, measuring of ’intensity’ aspects of alertness and
attention, as described by Konrad, Günther, Hanisch & Herpertz-Dahlmann [48]. On the
screen a (fixation) cross is continuously projected. This cross changes unexpectedly into a
square requiring the participant to press a mouse key as fast as possible, after which the square
turns into a cross again, and this is repeated in 32 trials. Main outcome parameters are reaction
time (RT), reflecting alertness, and the response speed stability (SD of RT), reflecting fluctua-
tion in alertness.
The SSV task aims at measuring inhibition and attentional flexibility. The signal consists of
a horizontal bar that is permanently present on which a square jumps randomly to the left or
the right. In part 1, participants have to copy the movement of a green-coloured square (press
left/right button on a left/right move). In part 2, participant have to do the opposite, i.e. ‘mir-
ror’ the movement of a red-coloured square, and in part 3, the square randomly changes col-
our, requiring participants to either copy or mirror the movement of the square. The contrast
between performances in part 1 and part 2 reflects inhibitory control; the contrast between
performances in part 1 and part 3 (compatible responses) reflects cognitive flexibility, with
larger values indicating poorer performance. Main outcome parameters of the SSV task are
reaction time and accuracy (percentage of errors).
The SAD task measures sustained attention, i.e. the ability to keep performance at a certain
level during a longer period of time. In this task, 600 dots patterns with 3, 4, or 5 dots appear
on a computer screen in 50 series of 12 trials, each consisting of three 3-dots, 4-dots, and
5-dots patterns, presented in a pseudo random order. Participants are required to respond to
4-dots patterns by pressing a mouse key with their preferred hand (‘yes’-response) and to press
the other mouse key with the non-preferred hand (‘no’-response) whenever 3- or 5-dots pat-
terns are shown. Inaccurate responses, misses (‘no’-responses to 4-dots) and false alarms
(‘yes’-responses to 3 or 5 dots) are directly followed by a beep signal. Task duration is approxi-
mately 15–20 min. Main outcome parameters are tempo (mean series completion time across
50 series), accuracy, and fluctuation in tempo. Fluctuation in tempo, the WS subject SD of 50
completion times, is taken as the primary index of sustained attention. As participants were
informed about errors by a beep signal, and correct responses following an error are separately
registered, post-error slowing (sensitivity to feedback) can be estimated.
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Measure of anxiety symptoms
The Dutch version of the Lehrer Woolfolk Anxiety Symptom Questionnaire (LWASQ) [49]
was used to measure the anxiety level. The LWASQ is a self-report, generic anxiety instrument
with 36 questions which assesses the cognitive (worry and rumination), behavioural (avoid-
ance) and somatic (physical symptoms) aspects of anxiety. In the present study, the difference
between pre- and post-measurement was used for further analysis. The reliability of the
LWASQ is sufficient (α = .83 tot .92) and the questionnaire is suitable for the measurement of
treatment effects [50].
Statistical analysis
Statistical analyses were conducted using SPSS statistics (version 23.0) [51]. All data was
checked for normal distribution using the Shapiro Wilk test, Q-Q plot and histogram.
Reasons for missing values were reported. Dropouts were compared to completers using
pre-test measures on age and anxiety score, by use of independent students t-tests. No signifi-
cant differences were found, so missing cases were listwise deleted and per protocol (PP) anal-
yses were performed for all outcomes.
The following hypotheses were tested:
1. AT results in higher resting HRV
2. AT results in a lower stress response: lower increase in HR and lower decrease in HRV
from resting to stress phase, respectively
3. AT results in faster recovery (HR) during cooling down
4. AT leads to improvements on self-reported daily EF
5. AT leads to improvements on performance-based EF
6. The reduction of anxiety symptoms is associated with improvements in stress recovery
7. The reduction of anxiety symptoms is associated with improvements of EF
Evaluation of treatment effects–stress regulation
To determine if the stress paradigm did work, we evaluated the changes in HR and HRV from
resting to stress and cool down phase, with all subjects of waitlist and treatment groups
included. Expected were an increase in stress level at the start of the stress induction phase
(shown as increase of HR and decrease of HRV) and a decrease during the cool down (shown
as decrease of HR and increase of HRV). This was tested with a general linear model repeated
measures analysis for variance (RM-ANOVA), with Test phase (resting, stress induction, cool-
ing down) as within-subject (WS) factor and the pre-test HR and HRVRMSSD as dependent
variable respectively, using a repeated contrast (resting vs. stress induction, stress induction vs.
cooling down).
To examine hypothesis 1, we tested whether the therapy had influenced resting HRV (rest-
ing phase) by using a RM- ANOVA with Test moment (pre- vs. post-test) as WS factor, Group
(AT vs. WL) as BS factor and resting HRVRMSSD as dependent variable.
Hypothesis 2 was tested using a RM-ANOVA with Test moment (pre- vs. post-test) as WS
factor, and Group (AT vs. WL) as BS factor, with stress response (stress induction HR minus
resting HR) as dependent variable. The same procedure was followed for HRVRMSSD (stress
induction HRV minus resting HRV).
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To examine hypothesis 3, to test whether the experimental group improved on downregula-
tion (recovery speed), we divided the Cooling down phase in nine slices of 30 seconds each
and analysed changes in HR during using a RM-ANOVA with the Cooling down phases (slice
1–9) and Test moment (pre- vs. post-test) as WS factors, Group (AT vs. WL) as BS factor, and
HR as dependent variable.
Evaluation of treatment effects–executive functioning
To examine hypothesis 4, a RM-ANOVA was performed, using Test moment (pre- vs. post-
test) as WS factor and Group (AT vs. WL) as BS factor, with BRIEF-A subscale (T) scores as
dependent variables, respectively.
To establish whether the study population deviated from the norm on performance-based
EF measured with the ANT, we performed a MANOVA, with the z-scores of alertness (speed,
fluctuation in speed), inhibition and flexibility (reaction time, error percentage) and sustained
attention (tempo, fluctuation in tempo, error percentage) as dependent variables, using the
intercept test for deviations from zero.
Subsequently, the treatment effects were evaluated (hypothesis 5) by means of RM-ANO-
VAs with Group (AT vs. WL) as BS factor and Test moment (pre- vs. post-test) as WS factor,
and the outcomes on alertness (reaction time, fluctuation in reaction time) and sustained
attention (tempo, fluctuation in tempo, error percentage) as dependent variables respectively.
To analyse treatment-related changes in inhibition and flexibility, differences scores were com-
puted for Inhibitory control and Cognitive flexibility, for both reaction time and error percent-
ages. These dependent variables were analysed with RM-ANOVAs, with Group (AT vs. WL)
as BS factor and Test moment (pre- vs. post-test) as WS factor.
For all analyses, a p-value of 0.05 was considered statistically significant. The effect size Par-
tial Eta Squared (ηp
2) was calculated to assess the relevance of the effect. An effect size of 0.01–
0.06 is considered a small effect, 0.06–0.14 a medium effect, and>0.14 a large effect in RM
analysis [52].
Exploration of associating factors
The sample size was calculated based on our primary aim to study the effectiveness of art ther-
apy. The secondary aim was to explore factors influencing anxiety reduction (testing hypothe-
ses 6 and 7). For this purpose, correlations were computed between the reduction in anxiety
score and the pre-post treatment differences in EF, and aspects of stress regulation (HR and
HRV). Only those aspects of EF and stress regulation that were demonstrated to improve sig-
nificantly after treatment within the experimental group were entered in the correlation analy-
sis. Only variables that significantly correlated with anxiety reduction were subsequently
entered in regression analysis. Hierarchical regression analyses were planned to examine
whether improvements of EF and stress recovery contributed to anxiety symptom reduction.
To examine baseline predictors of anxiety symptom reduction, regression analyses were
planned with the primary outcome variable (pre-post treatment difference in anxiety symptom
severity) compared to baseline variables (pre-treatment values).
Results
Anxiety symptom severity
In a previous paper [12] that reported on this RCT, was shown that anxiety symptom severity
was significantly reduced in the AT group but not in the WL group [F(1,45) = 11.49, p = 0.001,
ηp
2 = 0.20].
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The Within-Group outcomes are presented in Table 1.
Stress regulation
A number of measurements of participants (n = 11) could not be used due to a very distorted
signal (n = 6) or uncompleted tests due to refusal or impossibility of participants to complete
the paradigm (n = 5). To investigate whether there were outliers, the 1.5 x interquartile dis-
tance rule (IKA) was used. Analyses are carried out both with and without outliers. Because
this did not yield different results, the outcomes of the analyses with outliers are reported.
Evaluation of stress paradigm
The first WS contrast (resting vs. stress induction) revealed a significant effect for HR [F(1,51)
= 158.72, p<0.0001, ηp2 = .757] and HRV [F(1,51) = 5.666, p = 0.021, ηp2 = .100], respectively,
with HR increasing from [mean (SD)] 69,59 (9,58) to 90,28 (15,96), and HRV decreasing from
[mean(SD)] 40,02 (25,29) to 29,25 (25,25). The second contrast (stress induction vs. cool
down) showed a significant effect for HR [F(1,51) = 166.47, p<0.0001, ηp2 = .765] and HRV [F
(1,51) = 6.342, p = 0.015, ηp2 = .111], with HR decreasing from [mean(SD)] 90,28 (15,96) to
70,14 (9,83) and HRV increasing from 29,25 (25,25) to 42,27 (29,49). This confirms that the
stress paradigm worked: an increase of HR is shown in the stress induction phase and a
decrease is shown in the cool down phase as expected. The HRV decreases during stress induc-
tion and recovers during cool down.
Treatment effects on HRV
For HRVRMSSD, the interaction effect Test moment
�Group was trend significant [F(1,35) =
3.96, p = 0.054, ηp
2 = .102], indicating that the AT group improved more than the WL group.
This was further explored within the three phases. During resting phase, the interaction Test
moment�Group was significant [F(1,35) = 4.54, p = 0.04, ηp2 = .115], reflecting that the AT
group had a higher HRV during the resting phase at post treatment and the WL group had a
lower HRV at T1, indicating improved HRV in AT group only (Table 2 and Fig 2).
For the stress induction phase, no significant Test moment�Group interaction was shown
(p = 0.81) and in the cool down phase, the Test moment � Group interaction on HRV was
trend significant (p = 0.068): the WL group appeared to have a lower HRV at T1, compared to
T0, and the AT showed an increase of HRV at T1, indicating an improvement (Table 2 and Fig
3).
Treatment effects on stress responsivity (HR)
The RM-ANOVAs testing the treatment effects of AT on HR showed a significant main effect
for Test moment, indicating an increase in HR from pre- to post treatment [F(1,35) = 11.46,
p = 0.002, ηp2 = 0.247], but no significant Test moment � Group interaction (p = .649) (Fig 3).
Stress response was calculated as the difference in mean HR between stress induction phase
and resting phase. No significant differences in stress response were found between groups
(p = 0.444), indicating that there were no improvements in stress responsivity.
Treatment effect on stress recovery (HR)
Stress recovery was calculated as the difference in mean HR between stress induction phase
and cool down phase. No significant differences in stress recovery were found between groups
(p = 0.374), indicating that there were no improvements in stress recovery.
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Table 1. Anxiety symptom severity: Within-Group outcomes [12]. Mean, standard deviation, 95% CIs and p-values from pre- to post-treatment (paired t-tests).




Mean diff (SD); 95% CI p-values
Anxiety score
(LWASQ total
AT (n = 24)










AT (n = 24)





6,79 (10,25); 95%CI: 2,46–11,12




AT (n = 24)





5,54 (7,02); 95%CI: 2,58–8,51




AT (n = 24)











(p-values from RM-ANOVA’s with Test moment (pre- vs. post-test (T0 vs T1)) as WS factor, and Group (AT vs. WL) as BS factor, with anxiety score as dependent
variable)
https://doi.org/10.1371/journal.pone.0225200.t001
Table 2. Outcomes HRV and HR (stress regulation). Mean, standard deviation at pre- and post-treatment
(RM-ANOVA).
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AT (n = 19)






AT (n = 19)







AT (n = 19)






AT (n = 19)






AT (n = 19)






AT = treatment condition (3 months art therapy);
WL = waiting list condition;
T0 = pre measurement; T1 = post measurement
https://doi.org/10.1371/journal.pone.0225200.t002
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To test stress recovery speed, the cool down phase was analysed in slices of 30 seconds. No
differences between the groups were observed on HR, indicating that both groups did not dif-
fer in stress recovery speed.
Fig 2. Mean HRV.
https://doi.org/10.1371/journal.pone.0225200.g002
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Exploration of factors contributing to anxiety symptom reduction
The only aspect of stress regulation that improved (resting HRV) did not significantly correlate
to anxiety symptom reduction, so mediators and predictors were not analysed.
Fig 3. Mean HR.
https://doi.org/10.1371/journal.pone.0225200.g003
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Executive functioning–behavioural aspects
On the behavioural aspects of EF (BRIEF-A total score), the interaction effect Test
moment�Group was significant: F(1,44) = 827, p = 0.006, with a large effect size (ηp2 = .16),
showing that the total EF improved in the AT group but not in the WL group. Four of the nine
subscales of the BRIEF showed significant interactions on Test moment�Group: emotion con-
trol [F(1,44) = 4.26, p = 0.045, ηp2 = .09]; working memory [F(1,44) = 5.49, p = 0.024, ηp2 = .11];
plan/organize [F(1,44) = 5.87, p = 0.020, ηp2 = .12] and task monitor [F(1,44) = 10.79,
p = 0.002, ηp2 = .20], indicating that AT was effective in these domains. AT was not effective in
the domains inhibit (p = 0.13), shift (p = 0.24), self-monitor (p = 0.94), initiate (p = 0.66) and
organization of materials (p = 0.56) (Table 3).
Exploration of contributing factors
Only the variables that improved significantly in the AT group (analysed with a MANOVA
intercept test) were added in a regression analysis with the LWASQ difference score (pre-post
treatment). These variables were shift (cognitive flexibility), emotion control, plan/organize,
working memory and task monitor. A backward regression analysis with these variables
resulted in a significant model [F(3,22) = 13,09, p<0.0001, R2 = .674], consisting of three sub-
scales of the BRIEF, indicating that improvements in emotion control (β = .364, t = 2.54,
p = 0.020), plan/organize (β = .406, t = 2.76, p = 0.012), and task monitor, (β = .319, t = 2.21, p
= 0.039), explained 67,4% of the variance in anxiety symptom reduction.
Predictors
To explore possible predictors of therapy success, baseline scores of the subscales were used in
a backward regression analysis in relation to anxiety symptom reduction. This resulted in a
significant model [F(2,20) = 4,15, p = 0.031, R2 = .293] consisting of two subscales of the
BRIEF, showing that higher baseline scores of shift (β = .381, t = 2.02, p = 0.057) and organiza-
tion of materials (β = .347, t = 1.84, p = 0.081) led to larger reduction of anxiety symptoms, sug-
gesting that subjects who experience many problems with these EF aspects are more likely to
benefit from AT.
Executive functioning–cognitive aspects
Intercept tests on baseline z-scores showed that some of the EF variables deviated significantly
from the mean norm score, but were within normal range (-1 to 1): fluctuation in tempo:
[mean(SD)] 0.37 (1,16); F(1,44) = 4,61, p = 0.037, ηp2 = .095; accuracy (mistakes) in SSV1:
[mean(SD)] 0.63 (1.34); F(1,44) = 10,35, p = 0.002, ηp2 = .19; accuracy of inhibition: [mean
(SD)] 0,80 (2,26); F(1,44) = 5,68, p = 0.022, ηp2 = .114; accuracy of cognitive flexibility: [mean
(SD)] 0,68 (2,12); F(1,44) = 4,64, p = 0.037, ηp2 = .095.
The variable impulsivity falls within clinical range: [mean(SD)] 1,65 (1,65); F(1,44) = 57,07,
p<0.0001, ηp2 = .52. This indicates a clinical problem (poor inhibition) in this study
population.
Treatment effects
Due to procedural errors, three cases had to be excluded from analysis, two from the AT group
and one from the WL group. The RM-ANOVAs testing the treatment effects of AT on inhibi-
tion, cognitive flexibility and sustained attention showed no significant differences between
experimental group and control group (0.15<p<0.91). Some on the tasks showed significant
outcomes of test moment only, indicating a learning effect. This applied to inhibition (speed),
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flexibility (speed) and sustained attention (speed and stability), but not for number of errors on
the tasks and stability in speed in the inhibition and flexibility tasks. Outcomes of the tasks
(mean(SD)) are presented in Table 4.
Exploration of contributing factors
Since no significant treatment effects on cognitive performance EF were observed, associations
between performance EF and anxiety symptom reduction were not analysed.
Table 3. Outcomes BRIEF-A (executive functioning). Mean, standard deviation, p-values and effect sizes from pre- to post-treatment (RM-ANOVA).
Measure and condition T0 T1 Time�Group Effect size
Executive functioning Mean (SD) Mean (SD) F p (partial η2)
BRIEF-A total
AT (n = 24)







AT (n = 24)







AT (n = 24)
WL (n = 23)




AT (n = 24)







AT (n = 24)







AT (n = 24)







AT (n = 24)







AT (n = 24)







AT (n = 24)







AT (n = 24)







AT (n = 24)







AT (n = 24)






AT = treatment condition (3 months art therapy); WL = waiting list condition;
T0 = pre measurement; T1 = post measurement
https://doi.org/10.1371/journal.pone.0225200.t003
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Predictors
Performance-based inhibition scores at baseline did correlate to anxiety symptom reduction (r
= -.416; p = 0.043), indicating that that subjects with poorer inhibition showed a larger reduc-
tion of anxiety symptoms, suggesting these subjects are more likely to benefit from AT.
Table 4. Outcomes of ANT tasks BS, SSV, SAD (mean(SD)). Mean, standard deviation, p-values and effect sizes from pre- to post-treatment (RM-ANOVA).
Measure and condition T0 T1 Time�Group Effect size
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AT (n = 20)







AT (n = 20)









AT (n = 22)







AT (n = 22)







AT (n = 22)








AT (n = 22)






AT = treatment condition (3 months art therapy); WL = waiting list condition;
T0 = pre measurement; T1 = post measurement
https://doi.org/10.1371/journal.pone.0225200.t004
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Discussion
In this explorative study, the effects of AT on stress responsivity and executive functioning
were assessed in order to further study the effectiveness of AT in adult women with anxiety
and to explore possible working mechanisms of this treatment. Data were collected as part of a
single-blind RCT on the effectiveness of AT in women with anxiety disorders, comparing an
experimental AT treatment group and a waitlist control group [12].
Our first hypothesis that AT would contribute to better stress regulation, is partially sup-
ported. Subjects in the intervention group showed higher resting HRV after treatment, indicat-
ing a lower stress level and/or reduction of anxiety, meeting our expectation. The stress
response measured after treatment was however as strong as before the treatment and no
improvements in stress recovery were observed, contrary to our expectations.
Our second hypothesis that AT would result in executive functioning, was also partially
supported. The results of the self-reported EF show that there were significant improvements
in emotion control, working memory, plan/organize and task monitor, but the changes in AT
group in the domains inhibit, shift, self-monitor, initiate and organization of materials were not
significant compared to WL group. Regarding performance-based cognitive EF, there were no
significant post treatment differences between the experimental group and the control group
on Inhibition, Cognitive flexibility and Sustained attention.
The third hypothesis, that improvements in stress regulation and EF were associated with
anxiety symptom reduction, was only partly substantiated. Improvements in the self-reported
EF domains emotion control, plan/organize and task monitor were associated with anxiety
symptom reduction, with an explained variance of 67,4%. Analysis of predicting factors dem-
onstrated that lower Inhibition scores on performance EF at T0 were associated with larger
reduction of anxiety symptoms, and lower self-reported cognitive flexibility and organization of
materials were associated with a larger anxiety reduction.
Interpretation and comparison to literature
The finding that improvement of resting HRV was shown in the experimental group, indicates
an improved autonomic regulating ability [18, 53] and, according to the Neurovisceral Integra-
tion Model, an improved ANS regulation [54]. The higher resting HRV in the experimental
group may be indicative for a lower overall stress level and can be considered an index for
improved self-regulatory ability [55]. Because HRV is strongly associated with the presence of
an anxiety disorder [9, 21], and HRV is positively correlated with adaptive emotion regulation,
according to the Polyvagal Theory [16], the outcomes of this study substantiate our earlier
finding: anxiety symptom reduction and improvement of emotion regulation [12]. Further-
more, there is neurophysiological evidence for associations between resting HRV and execu-
tive brain regions [54]. Resting HRV does not only represent overall health, but is also an
index for the degree of brain flexibility concerning self-regulation processes, such as executive
functions and cognitive control [56, 57].
Subjects in the experimental group showed the same stress response as before treatment
and did not improve on stress recovery (down regulation). The fact that the stress response
after treatment did not differ from before treatment, can have several explanations. Firstly, it is
possible that subjects in the intervention group were just as sensitive/susceptible to stress
induction as before treatment, leading to the preliminary conclusion that AT does not affect
the direct stress response (stress responsiveness). In other studies it was shown that the stress
response did not differ between healthy populations, people with intense worry and patients
with GAD [58]. This implies that the stress response itself cannot easily be influenced. Sec-
ondly, the treatment period (three months) might have been to short and the number of
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sessions (10–12) too little to realize significant changes in stress responsiveness. Thirdly, the
Trier Social Stress task is originally developed to induce stress in healthy populations. A worry
task [9] may also be suitable for this study population and may lead to other outcomes.
Another important outcome is that the treatment group experienced improvements in
daily behavioural executive functioning in the domains emotion control, working memory,
plan/organize and task monitor, but did not show pre-post treatment differences regarding
performance-based executive functioning (Alertness, Inhibition, Cognitive flexibility and Sus-
tained attention) compared to the control group. It is known that self-report measures are
prone to a higher risk of bias / overestimation, due to positive expectations of the treated par-
ticipants and to placebo effects, which are thought to account for 15% of treatment effects [59].
Positive expectations generally lead to a more positive self-evaluation of mental health [60].
A possible explanation for not finding improvements in performance EF is that the study
population was not in the clinical range on this aspect (except for Inhibition), meaning that
there were no major problems with EF, thus making occurrence of improvement less likely.
On the other hand, the small sample size may also have compromised the outcomes. It is not
unlikely that significant improvements in accuracy (error percentages) of Inhibition and Cog-
nitive flexibility can be found in a larger study population, because these variables improved in
AT group and not in WL group.
The study population showed poorer Inhibition skills compared to a healthy study popula-
tion, and subjects with larger Inhibition problems showed a larger anxiety reduction. This is
consistent with several studies that showed that poor behavioural inhibition is associated with
anxiety and high physiological arousal [61].
Hypotheses on working mechanisms of AT
Although there is still much unclear about the exact working mechanisms of AT, the forgoing
results allow for the hypothesis that AT is effective in the treatment of anxiety symptoms due
to the improvement of specific aspects of self-regulation. In our study, AT led to improvement
in overall stress reduction (higher resting HRV), and the treated subjects reported improve-
ments in several aspects of executive functioning; emotion control, cognitive flexibility (shift),
working memory, plan/organize and task monitor.
This hypothesis can be substantiated by the body of knowledge on anxiety reduction, which
states that both higher resting HRV and improvements in EF contribute to lower anxiety lev-
els. These improvements may be caused by the therapy. Firstly, creating visual art is linked to
improved psychological resilience (i.e. stress resistance) on a neural level, due to improve-
ments in functional connectivity of the medial parietal cortex and the praecuneus [62]. Sec-
ondly, specific skills are practiced during the artistic exercises, which are carefully chosen by
the therapist. These exercises provide experiences within a safe environment and are not only
intended to gain insight in emotions and responses, but are also intended to practice skills
[63]. These skills may be related to aspects of executive functioning: e.g. following instructions
(working memory), working autonomously on an assignment (plan/organize), tracking and
evaluating own actions during the art work (task monitor), learn to interact with and adjust to
the qualities of different art materials (shift), and learn to explore and regulate their emotions.
This hypothetical working mechanism is substantiated by the finding that improvements of
the aspects emotion control, plan/organize and task monitor contributed for 64,7% of the anx-
iety symptom reduction through AT.
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Strengths, limitations and generalizability
Strengths of this study are that this is the first RCT on AT for anxiety studying clinical out-
comes and working mechanisms, with both self-reported and objective measurements and
analyses of outcomes and influencing factors. This study is important for the scientific under-
pinning of AT in general and for the AT treatment of anxiety disorders specifically. Based on
this study, specific hypotheses on working mechanisms can be formulated that can be tested in
further research.
Although this study provides important contributions to the sparse AT literature, it does
have some limitations. A first limitation is the lack of an active control group. It is therefore
not possible to conclude with certainty that the observed effects are caused by therapy-specific
factors. Second, the relatively small sample size may have compromised the outcomes and may
have led to non-detection of significant outcomes of stress responsivity and performance EF,
or to non-detection of associations between improvement of resting HRV and anxiety reduc-
tion. Also, the outcomes of the regression analyses should be handled with caution since the
small sample (n = 22) that was used for these analyses compromises the generalizability of
these results.
Third, cofounding and effect modifying factors such as cardiac comorbidities were not
measured, which could have influenced the HRV outcomes. Fourth, the study population con-
sisted of a specific subgroup: higher educated women, with a long duration of anxiety symp-
toms and probably with a specific motivation for the treatment, because the participants
applied for the study. This implies that the results are not generalizable to all women with anxi-
ety, nor to men [12].
Fifth, the study population was heterogeneous in nature, due to dimensional inclusion on
anxiety symptom severity. Participants did not belong to one specific anxiety disorder classifi-
cation, so conclusions on the effectiveness of art therapy for specific anxiety disorders cannot
be drawn. Sixth, this study did not result in a clear substantiation of the working mechanism
of art therapy, but led to preliminary hypotheses that need to be tested in further studies.
Because the present study was explorative in nature and had a small sample size, straightfor-
ward analyses have been performed in order to detect promising areas for further study. Some
insight into possible working mechanisms has been gained, but still many factors need to be
considered before concluding on the exact working mechanism(s) of art therapy.
Future perspectives
Outcomes of this study show that AT is a promising intervention for anxiety disorders, but
studies with active controls are needed to prove efficacy and cost-effectiveness of AT. Recom-
mendations are the testing of specific hypotheses in larger samples, testing with other objective
measures and/or a different psychophysiological protocol.
Hypotheses on working mechanisms generated from this study, regarding reduction of
anxiety symptom severity through improvements in self-reported daily executive functioning,
should be evaluated in future studies with larger samples, and should also include mediation
and moderation analyses, and should control for confounding and effect modification. Associ-
ations between outcomes on emotion regulation and executive functioning, and emotion regu-
lation and resting HRV, need to be explored as well in order to obtain a better understanding
of the route along which art therapy reduces anxiety symptom severity.
Because this explorative study contained a limited set of outcome measures, other hypothe-
ses on working mechanisms are possible and should be studied as well as well. For instance,
social regulation can be taken into account in future studies, as well as studying the effects of
AT on for example work and use of pharmacotherapy for anxiety.
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Other hypotheses need to be formulated more firmly and narrower, before new RCTs are
designed. Hypotheses can arise in general from expert experience, practice knowledge and sci-
entific literature. Since scientific literature on AT is in its infancy, expert experiences and prac-
tice knowledge should be used to provide input for specific clinically relevant hypotheses. Case
studies are suitable for this aim [64], because they can provide basic information on therapeu-
tic processes, are aimed at explicating expert experience and give insight in the approach that
is used in this intervention (www.care-statement.org). Case studies on AT may provide insight
in the route along the improvements of executive functioning and stress level are accom-
plished, which may further substantiate the preliminary working mechanisms found in this
study. In addition, case studies can be used to describe how positively tested interventions in
RCTs can be tailored to the needs of the individual patient.
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